Omicron Pharmaceuticals   Report issue

For profit Phase 2 Phase 3
Founded: Beirut Lebanon (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2011
NCT01286909
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Omicron Pharmaceuticals